|
AU2001237132B2
|
|
A method of treatment
|
|
US5629283A
|
|
Granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof
|
|
US5654176A
|
|
Fusion proteins containing glutathione-s-transferase
|
|
AU7151394A
|
|
Enhanced implantation, development and maintenance of embryos using leukaemia inhibitory factor
|
|
AU6640394A
|
|
Electrophoretic resolution of charged molecules
|
|
WO9425144A1
|
|
Electrophoretic resolution of charged molecules
|
|
US5536648A
|
|
Amplified DNA assay using a double stranded DNA binding protein
|
|
WO9421272A1
|
|
A method for treating microbial infection in an animal by administering a composition comprising lif and a cytokine
|
|
AU6369894A
|
|
A method for treating microbial infection in an animal by administering a composition comprising lif and a cytokine
|
|
EP0746569A1
|
|
Receptor-binding determinant from leukaemia inhibitory factor
|
|
AU5995994A
|
|
Receptor-binding determinant from leukaemia inhibitory factor
|
|
US6184370B1
|
|
Receptor-binding determinant from leukaemia inhibitory factor
|
|
AU5024093A
|
|
Method for the treatment of thrombocytopenia and pharmaceutical compositions useful therefor
|
|
SG64332A1
|
|
Monoclonal antibody
|
|
AU5145093A
|
|
Monoclonal antibody
|
|
US5747032A
|
|
Monoclonal antibody to human granulocyte macrophage colony stimulating factor
|
|
AU4412793A
|
|
Leukaemia inhibitory factor-binding protein
|
|
CA2139504A1
|
|
Leukaemia inhibitory factor-binding protein
|
|
WO9322347A1
|
|
Cytokine-like molecule and bioassay therefor
|
|
AU4255493A
|
|
Cytokine-like molecule and bioassay therefor
|
